EdgeMarket › Instruments › GTBP

GTBP — GT Biopharma, Inc.

Name: GTBP — GT Biopharma, Inc. market data and filings
Creator: EdgeMarket

US Healthcare Pharma & biotech equity mkt cap 13.0M

0.29 +3.78% today

USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown

52w low 0.27 · high 1.14

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-02-11.

Performance

1 day+3.78%

1 week-2.50%

1 month-13.90%

3 months-33.35%

6 months-37.26%

Year to date-64.68%

1 year-73.28%

3 years-96.16%

5 years-99.90%

Technicals

RSI 1442.8

vs 50-day avg-23.50%

vs 200-day avg-42.25%

Volatility 1y123.1%

Max drawdown 1y-76.14%

Avg volume 30d573.1K

Daily bars held1,388

History from2021-02-11

Others in Healthcare

LLY +0.9%AKTX +1.6%JNJ +1.1%ONC +1.5%ABBV +1.2%MRK +2.4%UNH +1.4%NVS +1.7%

Largest institutional holders

manager	value	shares
VANGUARD CAPITAL MANAGEMENT LLC	184.4K	451.9K
GEODE CAPITAL MANAGEMENT, LLC	120.2K	294.5K
VANGUARD FIDUCIARY TRUST CO	92.2K	225.9K
Arax Advisory Partners	38.2K	93.6K
CITADEL ADVISORS LLC	27.0K	66.2K
SeaCrest Wealth Management, LLC	20.4K	50.0K
UBS Group AG	18.8K	46.0K
TWO SIGMA SECURITIES, LLC	13.0K	31.8K
LPL Financial LLC	12.4K	30.4K
Invst, LLC	9.6K	23.4K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

form	filed	period
8-K	2026-08-14	2026-08-14	on EDGAR ↗
10-Q	2026-08-14	2026-06-30	on EDGAR ↗
DEF 14A	2026-07-02	2026-07-02	on EDGAR ↗
PRE 14A	2026-06-18	2026-06-18	on EDGAR ↗
8-K	2026-06-12	2026-06-08	on EDGAR ↗
8-K	2026-05-22	2026-05-20	on EDGAR ↗
10-Q	2026-05-15	2026-03-31	on EDGAR ↗
EFFECT	2026-05-13	—	on EDGAR ↗

Short selling

Avg short volume, 90d54.5% of tape

Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

GT Biopharma, Inc. (GTBP) filed form 8-K · 2026-08-14 · SEC EDGAR
GT Biopharma reports Q2 results · 2026-08-14
GT Biopharma, Inc. (GTBP) filed form 8-K · 2026-08-14 · SEC EDGAR
GT Biopharma, Inc. (GTBP) filed form 10-Q · 2026-08-14 · SEC EDGAR

Ask the AI about GTBP

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open GTBP in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Create a free account Open the terminal first

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →